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Introduction 
• Asthma is a common disease 
that is prevalent across the 
world. Asthma effects men, 
women, and children, and can 
have major public health 
consequences including 
morbidity and mortality 
(Dharmage et al., 2019). 
• It is estimated that around 300 
million people worldwide have 
been diagnosed with Asthma, 
and by 2025 it is estimated 400 
million people will have the 
disease (Dharmage et al., 2019). 
• Asthma is more prevalent in 
high income countries, 
however most cases of 
mortality occur in low income, 
3rd world countries (Dharmage 
et al., 2019). 
• Asthma has a significant 
economic burden on the United 
States. During the last study 
done, Asthma accounted for a 
total cost of $82 billion. The 
current-day total cost is 
estimated to be much higher 
(Nurmagambetov et al., 2018). 
• It is estimated that per-person, 
the average cost annually for 
healthcare services by an 
asthmatic is about $3,266. 
Pathophysiology 
• The pathophysiology of Asthma is 
very complicated. An 
exacerbation of the disease is 
usually sparked by factors that 
can induce airway inflammation 
leading to airway obstruction and 
hyperresponsiveness (Gans & 
Gavrilova, 2020). 
• Factors that can cause airway 
inflammation are allergens, 
infections, obesity, hormones, 
tobacco, smoke, exercise, cold 
air, genetic mutations, and 
eosinophilia (Gans & Gavrilova, 
2020). Other factors known to 
cause exacerbation are certain 
chemicals, insecticides, and 
pesticides (Mattila et al., 2021). 
• Chronic irritation and 
inflammation can cause airway 
edema, increased mucous 
production, mucus plugging, and 
overall airway remodeling from 
hyperplasia (Gans & Gavrilova, 
2020). 
• Upregulation and activation of 
leukocytes are responsible for the 
heightened immune response. 
Neutrophils, Eosinophils, and 
different types of T helper cells 
direct the immune response of 
the body (Mattila et al., 2021). 
(Asthma Foundation, 2021) 
Signs & Symptoms of Exacerbation 
Signs and Symptoms of asthma are 
nonspecific and vary from case to 




• Inspiratory wheeze 
• Expiratory wheeze 
• Tachycardia 
• Breathing accessory muscle use 
(Asthma Zones, 2021) 
(Asthma Diagnosis Treatment, 2021) 
(continued) 
• Chest tightness 
• Increased mucous production 






(Wu et al., 2020) 
• Peak expiratory flow (PEF) is a simple way to gauge the maximal 
expiratory flow rate that can be achieved after a full inspiration. 
The technique is beneficial to monitor for potential asthma 
exacerbation. After a baseline expiratory flow is achieved, daily 
measurements are compared to the initial value to assess 
impending/potential exacerbation (DeVrieze et al.,2020). 
• Based on certain measurement criterion, the PEF places the patient 
into a zone. The Green Zone is PEF of >80% compared to baseline. 
The Yellow Zone is PEF of 50-80% compared to baseline. The Red 
Zone is PEF <50% of baseline. Recommendations based on zone are 
provided by the patient’s medical provider. The Red Zone is the 
most critical and recommends the patient seek medical attention 
(OSF Healthcare, 2020). 
(Cleveland Clinic, 2021) 
Treatment 
• Asthma is a complex heterogeneous disease that 
varies from patient to patient. Each treatment 
regimen requires an individualized approach by the 
provider. Asthma treatment is treated 
pharmacologically with inhaled medications and 
behaviorally by modifying potential at risk behaviors 
(Jones et al., 2018). 
• Behavioral modifications for treatment include 
smoking cessation and avoiding triggers such as 
harmful allergens, pollens, chemicals, and smoke 
(Wu et al., 2019). 
• Medication interventions include a short-acting beta 
adrenergic (SABA) rescue inhaler (ex. albuterol) for 
short term control, a long-acting beta adrenergic 
(LABA) inhaler (ex. formoterol) for long term control, 
and an inhaled corticosteroid (ex. budesonide) to 
complement the LABA for long term management 
(Ohbayashi et al., 2018). 
• A stepwise approach is usually utilized to help 
manage asthma in adults. Depending on the severity 
and frequency of symptoms, a medication step tool 
helps a clinician to prescribe needed medications to 
prevent exacerbation (National Asthma Education 
and Prevention Program, 2007). 
• All asthma patients are prescribed a short-acting 
beta adrenergic (SABA) rescue inhaler. Intermittent 
asthma usually only requires a SABA rescue inhaler. 
Mild to persistent asthma patients are typically 
prescribed a low to moderate dose LABA inhaler, as 
well as low to moderate dose inhaled corticosteroid. 
Severe persistent asthma patients require high dose 
LABA inhalers and high dose inhaled corticosteroids 
(National Asthma Education and Prevention 
Program, 2007). 
(National Asthma Education and Prevention, 2007) 
Nursing Implications 
The Doctorate of Nursing (DNP) 
prepared nurse plays a vital role in 
the diagnosis and treatment of 
asthma. It is important that the 
nurse recognizes the signs and 
symptoms that point to acute 
exacerbation and intervene when 
indicated. 
Nursing Interventions: 
• Proper auscultation and 
identification of breath sounds 
• Education of pursed lip 
breathing technique 
• Proper application of 
supplemental oxygen 
(Saturation goal >92%) 
• Ability to place patient in up-
right, high fowlers position 
• Education and demonstration of 
spacer use for inhalers 
• Proper administration of 
SABA/LABA nebulizers and 
inhalers when indicated 
• Education of SABA/LABA 
nebulizers and inhalers 
• Education of corticosteroids and 
risks of use including thrush .
• Education on Green-yellow-red 
zones and when to see medical 
attention 
• Use of therapeutic 
communication to alleviate 
patient concerns and distress 
Conclusions 
The impact of asthma is far reaching. 
An in-depth examination of the 
disease shows that it is important 
for the DNP prepared nurse to be 
well versed in diagnosing and 
managing this disease. Further 
research is indicated in this field to 
help better manage the disease and 
help improve patient outcomes. 
New research may lead to ways to 
lessen the economic burden caused 
by asthma as well. 
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